WO2011008028A9 - Functional drinking water for improving blood circulation, and method for preparing same - Google Patents

Functional drinking water for improving blood circulation, and method for preparing same Download PDF

Info

Publication number
WO2011008028A9
WO2011008028A9 PCT/KR2010/004590 KR2010004590W WO2011008028A9 WO 2011008028 A9 WO2011008028 A9 WO 2011008028A9 KR 2010004590 W KR2010004590 W KR 2010004590W WO 2011008028 A9 WO2011008028 A9 WO 2011008028A9
Authority
WO
WIPO (PCT)
Prior art keywords
water
drinking water
blood circulation
functional
present
Prior art date
Application number
PCT/KR2010/004590
Other languages
French (fr)
Korean (ko)
Other versions
WO2011008028A3 (en
WO2011008028A2 (en
Inventor
박경배
Original Assignee
주식회사 메자이텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 메자이텍 filed Critical 주식회사 메자이텍
Publication of WO2011008028A2 publication Critical patent/WO2011008028A2/en
Publication of WO2011008028A3 publication Critical patent/WO2011008028A3/en
Publication of WO2011008028A9 publication Critical patent/WO2011008028A9/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health

Definitions

  • the present invention relates to a functional drinking water for improving blood circulation and a preparation method thereof.
  • the circulation of blood circulates our bodies along the blood vessels around the heart, supplying oxygen to the tissues of the body, releasing carbon dioxide, nutrients, and metabolites. It carries hormones from the endocrine gland to regulate the function of specific organs, and it is also a process of controlling pathogens, controlling body temperature, controlling osmotic pressure, and controlling water.
  • Blood vessels consist of arteries, capillaries, and veins.
  • the artery is composed of outer elastic membrane and connective tissue, outer membrane and smooth muscle, medial membrane containing many elastic fibers, innermost endothelial cells, and connective tissue and elastic fibers surrounding it. It consists of the inside.
  • Capillaries are small arteries and small veins that are connected to the artery and are thinly branched with a net shape of 0.008 to 0.02 mm in diameter. Red blood cells pass through 1-2 lines and are not visible to the naked eye. And nutrients are sent into the tissue, and the CO 2 and waste products produced by the tissue enter the blood vessels.
  • the vein's outer membrane is relatively thick, the inner and middle membranes are thin, there is no pressure, and the blood flow is weak compared to other blood vessels.
  • blood circulation disorder is a disease in which the blood pumped from the heart returns to the heart through arteries, capillaries, and veins, and these blood vessels are blocked or not easily circulated.
  • blood from the heart decreases in blood pressure toward the distal end of the body.
  • the blood vessel walls become narrower and blood vessels narrow and blood circulation does not work smoothly, resulting in diseases such as stroke and coronary artery disease. May cause.
  • these blood circulation disorders include vascular related diseases such as atherosclerosis, high blood pressure, heart disease, and diabetic complications, as well as menopausal symptoms, numbness, tinnitus, headache, dizziness, chronic fatigue, and muscle clumping or coughing. It is also associated with symptoms such as memory loss, difficulty concentrating, and depression, and can cause a variety of complications.
  • Hyperlipidemia and hypertriglyceridemia in which blood cholesterol levels rise above a certain level may lead to deterioration of blood flow, elevated blood pressure, and impaired blood circulation in blood vessels due to an increase in blood viscosity and atherosclerosis.
  • red blood cells and white blood cells should be well dispersed without intertwining each other and able to pass through the capillaries. Colloids are in suspension because they have a slight negative electrical charge on the surface of each particle.
  • Blood is a type of colloidal solution, and all blood cells have a slight negative charge. Particles of the same charge repel each other and disperse well.
  • the surface charge of such particles is called the zeta potential (ZP) and negatively expressed in -mV units.
  • ZP zeta potential
  • the aggregation of blood begins when the absolute value of the zeta potential is very low, which is known as intravascular coagulation.
  • the life activity of the human body is a life complex consisting of somatic cells (60 trillion) of clam and intestinal microbial cells of clam, or 200 trillion cells.
  • the human body is composed of intracellular and extracellular fluid.
  • the intracellular fluid is 30-40% of the body weight
  • the extracellular fluid is 20-25% of the body weight
  • the blood is 83%. Therefore, metabolism can be smoothly performed when water is well absorbed into specific cells.
  • Korean Patent Laid-Open Publication No. 2006-108191 discloses an alkaline reduced water generating device in the form of a circulating flow path so that water supplied or stored in a cold water container or a reservoir can always be maintained in a functional water having a certain level of functionality. Doing.
  • Korean Patent Publication No. 2002-46369 discloses a one-step purification process for purifying hazardous contaminants contained in tap water using a plurality of water filters; A two-stage purification step of electrolyzing the water purified in the first step through a medical material generating device;
  • a four-stage purification step of colliding water molecules by passing the water purified in the three-stage through a ceramic medallion and a metal oxide ore of magnetite;
  • Japanese Patent Application Laid-Open No. 2005-28341 passes water in which silica fine particles are dispersed in the waveform distribution space of electromagnetic waves, thereby raising the absolute value of the zeta potential of the water to 20 mV to 60 mV to continuously maintain water functions such as solubility and permeability. It provides a function number to do.
  • the functional water cannot be used as drinking water by law by using insoluble silica fine particles.
  • the present inventors have studied to develop drinking water that can improve blood circulation without adding any organic substances such as drugs or dietary supplements.
  • the surface tension is improved by controlling the hardness and pH of drinking water, adding silicon minerals, and magnetizing.
  • the water is immediately absorbed into the blood vessels when drinking, and interacts with the blood, increasing the zeta potential of the water to lower the viscosity of the blood, and maintaining the normal zeta potential of the blood to find out that the blood circulation can be smoothed.
  • the surface tension is improved by controlling the hardness and pH of drinking water, adding silicon minerals, and magnetizing.
  • An object of the present invention is to provide a functional drinking water for improving blood circulation having high zeta potential and low surface tension.
  • Another object of the present invention is to provide a method of producing functional drinking water for improving blood circulation.
  • Another object of the present invention is to provide a method of lowering the surface tension of water by adding sodium silicate to water.
  • Still another object of the present invention is to provide a functional drinking water discharging functional drinking water for improving blood circulation.
  • the present invention provides a functional drinking water for improving blood circulation prepared by magnetizing after adding sodium silicate to drinking water.
  • the present invention comprises the steps of dissolving a water-soluble silicate in a general drinking water of 40 ⁇ 120 mg / l hardness so that the concentration is 22.4 ⁇ 45 mg / l (step 1);
  • It provides a method for producing the functional drinking water for improving blood circulation comprising the step (step 2) of the silicate solution prepared in step 1 to pass through the magnetized active water production apparatus.
  • the present invention provides a method of increasing the zeta potential of water by adding sodium silicate to water.
  • the present invention also provides a method of lowering the surface tension of water by adding sodium silicate to water.
  • the present invention provides a functional drinking water dispenser for discharging the functional drinking water for improving blood circulation.
  • the cluster of water is small so that water is easily absorbed into cells and thus blood.
  • FIG. 1 to 4 are photographs showing the effect of functional drinking water or general drinking water on the freshness of strawberries according to an embodiment of the present invention.
  • 5 to 7 are photographs showing the effect of functional drinking water or general drinking water on the freshness of a rose according to an embodiment of the present invention.
  • FIG. 8 is a photograph showing the effect of the functional drinking water or physiological saline according to the present invention the aggregation of blood.
  • FIG. 9 is a functional drinking water container according to an embodiment of the present invention.
  • the present invention provides a functional drinking water for improving blood circulation.
  • the functional drinking water according to the present invention preferably contains water-soluble silicate and is magnetized to have a pH of 7.5 to 9.0, a zeta potential of -14 to -30 mV, and a surface tension of 55 to 62 mN / m.
  • the present invention comprises the steps of dissolving a water-soluble silicate in a general drinking water having a hardness of 40 ⁇ 120 mg / L so that the concentration is 22.4 ⁇ 45 mg / L (step 1);
  • It provides a method for producing the functional drinking water for improving blood circulation comprising the step (step 2) of the silicate solution prepared in step 1 to pass through the magnetized active water production apparatus.
  • the present invention provides a method of increasing the zeta potential by adding silicate to water.
  • the present invention also provides a method of reducing surface tension by adding silicate to water.
  • Blood performs a constant movement at a constant temperature and pH, but the concentration of the electrolyte is not fixed and the electrolyte directly affects the zeta potential.
  • Anionic electrolytes increase the zeta potential.
  • the valence of ions has a profound effect on electrophoretic mobility and appears to varying degrees, but is also associated with the zeta potential amplification of colloids.
  • bivalent cations are about 20-80 times more effective than single-valent cations in the aggregation of electronegative colloids.
  • polyvalent anions increase the dispersibility by preventing aggregation.
  • drinking eight or more cups of water (pH 8.0-8.4) mixed with potassium citrate and potassium bicarbonate may reduce coagulation in the blood vessels.
  • so-called "EDTA chelation therapy" which removes toxic heavy metals in the body while increasing zeta potential using EDTA which forms a complex with metal ions is known.
  • the drinking water (tap water, spring water, water purifier, etc.) we drink includes cations such as Ca 2+ , Mg 2+ , Na + , K + , and SO 4 2- , CO 3 2- , Cl Anions such as - and HCO 3 - are mixed.
  • the magnetization treatment can be changed to about -8 to -15 mV, but the concentration (or hardness) of the cations and anions in the water varies depending on the water intake zone or water purification method.
  • mineral salts were added to the water to approach -18 ⁇ -25 mV, similar to the zeta potential of normal blood.
  • silicate sodium silicate
  • Dissolved minerals in water are essential for drinking water, and especially in deep sea water, about 60 kinds of minerals that have been balanced for many years are dissolved. .
  • Si silicon
  • Silicon is known to be essential for normal bone growth and to increase calcium absorption in bone.
  • Atherosclerosis is known to be responsible for the decrease in the content of silicon in the arterial vessel walls. Therefore, it is very important to increase the zeta potential and increase the silicon content in the blood.
  • the silicate is well suited because it is well soluble in water and has a silicate anion.
  • the silicate is an alkaline aqueous solution when dissolved in water, it is also advantageous to convert the acidic constitution to alkaline constitution.
  • Na 4 SiO 4 , Na 6 Si 2 O 7 , Na 2 SiO 3 and the like may be used as the water-soluble silicate, but Na 2 SiO 3 may be used as the most preferable silicate.
  • the zeta potential may be different depending on the mineral concentration of the spring water
  • the hardness is 40 mg / l or less
  • the hardness is 40 ⁇ 120 mg / l by adding an appropriate amount of deep seawater or coastal deep water containing a large amount of natural minerals. It is preferable to adjust so as to add silicate and magnetize.
  • various kinds of water such as spring water, tap water, water purifier passing water, marine or coastal deep water, and hot spring water, which meet drinking water quality standards, may be applied.
  • the magnetized active water production apparatus may use a magnetized active water production apparatus used in the art, but is not limited thereto.
  • the apparatus for producing magnetized active water disclosed in Korean Patent Registration No. 0722302 may be used.
  • the functional drinking water according to the present invention reduces the surface tension.
  • Suitable silicate concentration is preferably 0.15 to 0.3% in the range of alkaline pH 7.5 ⁇ 9.0, and the concentration of Na 2 SiO 3 at this time (0.15%) corresponds to 22.4 ⁇ 45 mg / l.
  • Functional drinking water according to the present invention has a high zeta potential and low surface tension can be quickly absorbed into the blood vessels and can maintain a smooth blood circulation by increasing the dispersion of red blood cells and white blood cells in the blood.
  • the functional drinking water according to the present invention is effective in the blood circulation, put the strawberry or rose in the functional drinking water and the general drinking water according to the present invention and observed freshness while leaving at room temperature for 3 to 4 days, general drinking water Strawberries or roses put on it easily decay and appear mildewed,
  • Strawberries or roses in functional drinking water according to the present invention was found to remain fresh in its original form (see FIGS. 1 to 7 ).
  • the drinking water according to the present invention is well absorbed into the plant tissue and it can be seen that the circulation of sap smoothly and smoothly.
  • the blood circulation of the capillaries of the distribution plate was observed in the ring finger, after 30 seconds after drinking the functional drinking water according to the present invention, the blood circulation proceeds rapidly. Appeared.
  • the functional drinking water according to the present invention can be usefully used to improve blood circulation.
  • Functional drinking water according to the present invention can be used directly without processing, or can be used as a solvent of various mixed drinks, ginseng, green tea, herbal medicines, extracts, various liquors such as rice wine, shochu, beer, wine; It can be used for medical sap preparations such as saline solution and glucose ringer.
  • Functional drinking water according to the present invention can be produced directly at home, and when using tap water and water purifier, the installation of silicate reservoir and inlet flow control valve, self-activated active water production equipment in the existing water purifier system in front of the outlet, the functional water directly at home Can be used to create.
  • the present invention provides a drinking water dispenser for discharging the functional drinking water.
  • Raw water supply unit 100 for supplying raw water
  • Storage vessel 200 for storing the water-soluble silicate
  • a silicate inflow control valve 300 in communication with the storage container for discharging the water-soluble silicate by a predetermined amount
  • Magnetized active water production apparatus 400 for magnetizing by mixing the raw water supplied from the raw water supply and the silicate discharged through the silicate inflow control valve;
  • It may include a functional water discharge unit 500 for discharging the functional drinking water produced by the magnetized active water production apparatus through the discharge cock via the functional water pipe.
  • the raw water supply unit 100 may be connected to a water purifier, ionizer, bottled water tank or tap water.
  • the storage container 200 stores the water-soluble silicate, the silicate is discharged through the silicate inflow control valve.
  • the water-soluble silicate is preferably Na 2 SiO 3 , the concentration is preferably 22.4 ⁇ 45 mg / l.
  • the magnetized active water producing apparatus 400 is moved, and the magnetizing active water producing apparatus is used in the art.
  • a water manufacturing apparatus may be used, but is not limited thereto.
  • the apparatus for producing magnetized active water disclosed in Korean Patent Registration No. 0722302 may be used.
  • the functional drinking water produced in the magnetized active water production apparatus may be discharged to the functional water discharge unit 500 to be used.
  • the zeta potential before and after passing the magnetized active water generator of general drinking water was measured using a zeta potential measuring device (Particle Size / Zeta Potential Analyzer, Brookhaven Instruments Cooperation) and the results are shown in Table 1. The measured value was measured continuously 5 to 10 times and displayed as an average value.
  • the zeta potential is measured when the particles are present in the colloidal form in the solution, and the larger the value in the negative direction, the better the particles can be dispersed by mutual electrical repulsion.
  • Table 1 sample Average Zeta Potential (mV) Standard error Increment (-mV) Distilled water -3.75 1.47 Distilled Water (Magnetic Treatment) -11.22 1.13 7.47 Tap Water A -7.64 0.91 Tap water A (magnetization) -15.68 0.57 8.04 Tap Water B -4.67 0.63 Tap water B (magnetization) -14.37 1.58 9.70 Divisor A -8.87 1.92 Divisor A (Magnetization) -16.40 2.17 7.53 Groundwater A -8.16 1.21 Groundwater A (magnetization) -13.27 0.81 5.11
  • the zeta potential of non-magnetized drinking water ranged from -3.75 to -8.87 mV
  • the zeta potential after magnetization was -11.22 to -16.40 mV, ranging from 5.11 to 9.70 in the negative direction. It can be seen that the mV increased. Therefore, it can be seen that the dispersion force increases after the magnetization treatment.
  • 0.2 ml of sodium silicate (15%) was added to 100 ml of ground water A in Table 1, and diluted with magnetization to prepare a functional drinking water according to the present invention, and the zeta potential of the functional drinking water was measured by 10 in the method of Example 1. Measured continuously.
  • the functional drinking water according to the present invention may be included in the zeta potential range of normal blood to help smooth blood circulation.
  • the surface tension was reduced to 64.7 mN / m when the concentration of sodium silicate was 0.1% compared to the surface tension (72.66 mN / m) of the control group (distilled water),
  • functional drinking water magnetized by adding sodium silicate according to the present invention has a lower surface tension than ordinary distilled water, so that the population of water can be miniaturized. Can promote.
  • Each drinking water was placed in a glass bowl and left for 3 to 4 days to compare the growth of the fungus or fungus with a camera.
  • Figure 2 (a) is a strawberry in tap water, (b) is a strawberry in functional drinking water according to the present invention.
  • Figure 3 (a) is a strawberry in domestic drinking water, (b) is a strawberry in functional drinking water according to the present invention.
  • Figure 4 (a) is a strawberry in deep sea water, (b) is a strawberry in functional drinking water according to the present invention.
  • Figure 5 (a) is a rose plugged in hydrogen water, (b) is a rose plugged in functional drinking water according to the present invention.
  • Figure 6 (a) is a rose plugged into the deep sea water, (b) is a rose plugged into the functional drinking water according to the present invention.
  • Figure 7 (a) is a rose plugged into the domestic weak water, (b) is a rose plugged into the functional drinking water according to the present invention.
  • the rose inserted into the general drinking water was easily withered, while the rose inserted into the functional drinking water according to the present invention was found to be kept fresh.
  • Blood circulation of the distribution plate capillaries in the ring finger was observed after drinking normal drinking water using a portable peripheral capillary observation microscope (Firu Corporation, Japan) and after drinking the functional drinking water according to the present invention.
  • the blood circulation rapidly progressed after 30 seconds after drinking the functional drinking water according to the present invention, and it was confirmed that there is a distinct difference compared to drinking normal drinking water.
  • the functional drinking water according to the present invention can lead to a healthy life by preventing blood circulation disorder by showing an effect on improving blood circulation.
  • blood diluted with physiological saline shows a phenomenon in which red blood cells are collected and form a colony
  • blood diluted with functional drinking water according to the present invention is relatively well dispersed and aggregated. Therefore, the functional drinking water according to the present invention can be usefully used for improving blood circulation since the blood is well dispersed.
  • the functional drinking water according to the present invention can be utilized as Ringer's solution injection.

Abstract

The present invention relates to functional drinking water for improving blood circulation and to a method for preparing same. More particularly, the present invention relates to functional drinking water for improving blood circulation and to a method for preparing same, wherein a silicate is added to drinking water such as tap water, spring water, water purified by a water purifier, deep sea water, distilled water, etc., to bring the pH of the water to 7.5 to 9.0, and then the water is magnetized to provide functional drinking water having a zeta potential of -14 to -30 mV and a surface tension of 55 to 62 mN/m. The functional drinking water according to the present invention has the physical property of the zeta potential increasing in the negative (-) direction as compared to general water (having a zeta potential of -2 to -10 mV and a surface tension of 72 mN/m). Thus, when drunk, the drinking water of the present invention promotes the scattering of erythrocytes and thus improves blood circulation, and accelerates the nutrient-carrying capacity of the erythrocyte and lymphocyte blood cells. The drinking water of the present invention has a low surface tension to easily dissolve and remove waste substances and toxic substances from the body, and thus is significantly effective in promoting a healthy lifestyle.

Description

혈액순환 개선용 기능성 음용수 및 이의 제조방법Functional drinking water for improving blood circulation and preparation method thereof
본 발명은 혈액순환 개선용 기능성 음용수 및 이의 제조방법에 관한 것이다. The present invention relates to a functional drinking water for improving blood circulation and a preparation method thereof.
인간과 동물은 그 생명을 유지하기 위하여 산소, 영양분, 호르몬, 효소 등의 필요한 물질들을 혈액 순환을 통하여 신체의 각 장기 및 조직에 공급하고, 이산화탄소 및 각종 노폐물을 배출한다. Humans and animals supply necessary substances such as oxygen, nutrients, hormones, and enzymes to each organ and tissue of the body through blood circulation, and release carbon dioxide and various wastes to maintain their life.
혈액순환(the circulation of blood)이란 혈액이 심장을 중심으로 혈관을 따라 우리의 신체를 순환하는 것으로 산소를 신체 각 조직에 공급하고 탄산가스를 방출하고, 영양소를 보급하고 대사 산물을 방출하며, 여러 내분비선에서 호르몬을 운반하여 특정기관의 기능을 조절하며 그밖에 병원균 조절작용과 체온조절, 삼투압 조절, 수분조절 등의 기능을 수행하는 과정이다. The circulation of blood circulates our bodies along the blood vessels around the heart, supplying oxygen to the tissues of the body, releasing carbon dioxide, nutrients, and metabolites. It carries hormones from the endocrine gland to regulate the function of specific organs, and it is also a process of controlling pathogens, controlling body temperature, controlling osmotic pressure, and controlling water.
혈관은 동맥, 모세혈관, 정맥으로 구성되어 있다.  Blood vessels consist of arteries, capillaries, and veins.
동맥은 외탄력선판과 결합조직으로 되어 있는 외막, 평활근이 많고, 그 안에 다수의 탄력섬유를 함유하고 있는 중막, 제일 안쪽의 내피세포와 그것을 둘러싸고 있는 결합조직과 탄력섬유가 모여서 내강성판으로 되어 있는 내막으로 이루어져 있다. 모세혈관은 소동맥과 소정맥이 연결된 것으로 그물모양으로 가늘게 가지가 나 있으며 직경 0.008~0.02 mm의 가는 관으로서 적혈구가 1~2줄로 통과될 정도이고 육안으로는 보이지 않으며, 이 모세혈관을 통해서 혈액 중의 산소와 영양분은 조직 내로 보내지고 조직에서 만들어진 CO2나 노폐물은 혈관으로 들어온다. The artery is composed of outer elastic membrane and connective tissue, outer membrane and smooth muscle, medial membrane containing many elastic fibers, innermost endothelial cells, and connective tissue and elastic fibers surrounding it. It consists of the inside. Capillaries are small arteries and small veins that are connected to the artery and are thinly branched with a net shape of 0.008 to 0.02 mm in diameter. Red blood cells pass through 1-2 lines and are not visible to the naked eye. And nutrients are sent into the tissue, and the CO 2 and waste products produced by the tissue enter the blood vessels.
정맥의 외막은 비교적 두껍고 내막과 중막은 얇으며 압력이 없고 다른 혈관에 비해 혈류가 약하여 심장보다 낮은 부분의 정맥에서 역류할 위험성이 있기 때문에 역류 방지용 판막(valve)이 붙어 있다. The vein's outer membrane is relatively thick, the inner and middle membranes are thin, there is no pressure, and the blood flow is weak compared to other blood vessels.
통상 혈액순환장애란 심장에서 펌프되어 나온 혈액이 동맥, 모세혈관, 정맥을 거쳐 다시 심장으로 돌아오는데 이들 혈관이 막히거나 순환이 용이하지 않는 질환이다. In general, blood circulation disorder is a disease in which the blood pumped from the heart returns to the heart through arteries, capillaries, and veins, and these blood vessels are blocked or not easily circulated.
특히 심장에서 나오는 혈액은 심장에서 멀리 떨어진 신체 말단부위로 갈수록 혈압이 낮아지는데, 노화가 진행되면 혈관벽의 탄력성이 떨어지고 혈관이 좁아지면서 혈액순환이 원활하게 이루어지지 않기 때문에, 뇌졸중과 관상동맥 질환 등의 질병을 유발할 수 있다. In particular, blood from the heart decreases in blood pressure toward the distal end of the body. As aging progresses, the blood vessel walls become narrower and blood vessels narrow and blood circulation does not work smoothly, resulting in diseases such as stroke and coronary artery disease. May cause.
종래에는 혈액순환 장애로 인한 이러한 질병들은 노화나 유전적인 요인으로 인해 발생하는 경우가 많았다. In the past, these diseases due to blood circulation disorders were often caused by aging or genetic factors.
그러나, 현대사회가 서구화되면서 잘못된 식생활과 스트레스, 운동부족 등으로 인해 지방과 이물질이 혈관 벽에 쌓여 혈관이 좁아지고 혈관의 탄력성이 감소됨으로 인해 야기되는 혈액순환장애는 다양한 연령층에서 다양한 질병과 증상을 만들어내고 있다. However, the blood circulation disorder caused by fat and foreign substances accumulating on the walls of blood vessels due to poor eating habits, stress, and lack of exercise due to the westernization of modern society, narrowing blood vessels and reducing the elasticity of blood vessels has caused various diseases and symptoms in various age groups. I'm making it up.
예를 들어, 이러한 혈액순환장애는 동맥경화증, 고혈압, 심장질환, 당뇨합병증 등의 혈관 관련 질환은 물론, 여성의 갱년기 증상이나 손발저림, 이명, 두통, 현기증, 만성피로, 근육의 뭉치거나 뻐근한 현상, 기억력 감퇴, 집중력 장애, 우울감 등의 증상들과도 관련이 되어 있고, 다양한 합병증을 유발하기도 한다. For example, these blood circulation disorders include vascular related diseases such as atherosclerosis, high blood pressure, heart disease, and diabetic complications, as well as menopausal symptoms, numbness, tinnitus, headache, dizziness, chronic fatigue, and muscle clumping or coughing. It is also associated with symptoms such as memory loss, difficulty concentrating, and depression, and can cause a variety of complications.
따라서 이러한 혈액순환의 장애를 예방 또는 개선하기 위하여 많은 연구와 노력이 지속적으로 이루어져 왔다. 지금까지 여러 종류의 약품이나, 건강보조식품, 의료기기, 운동기구 등이 사용되고 있지만, 근본적인 문제 해결에는 아직 역부족이다. 그러므로 치료보다는 예방이 중요시되고 있다.  Therefore, many studies and efforts have been continuously made to prevent or improve such disorders of blood circulation. Until now, various kinds of medicines, health supplements, medical devices, exercise equipments, etc. have been used, but they are still insufficient to solve fundamental problems. Therefore, prevention is more important than cure.
혈액순환 장애의 개선을 위한 종래의 기술로서는 가시오가피, 두충 등의 추출물, 비타민E 및 은행잎 추출물이 함유된 조성물(공개특허 2001-19396호), 정제 어유, 화분 추출분말, 마늘유, 대두유, 레시친 등을 함유하는 청혈 기능을 갖는 건강보조식품(공개특허 제 2003-89537호), 자석이나 옥돌, 토르말린 등에서 방출되는 원적외선 및 음이온을 이용한 각종 팔찌, 목걸이, 침대, 의류 등의 건강 용품들이 주류를 이루고 있다. 그러나 그 효능을 검증하기 위한 객관적인 지표나 방법이 많지 않다는 단점이 있다.  Conventional techniques for improving blood circulation disorders include extracts such as thorny scabies, worms, vitamin E and ginkgo biloba extracts (Patent No. 2001-19396), refined fish oil, pollen extract powder, garlic oil, soybean oil, lecithin, etc. Health supplements having a blue blood function containing a public health (Public Patent No. 2003-89537), a variety of health products such as bracelets, necklaces, beds, clothing using far infrared rays and anions emitted from magnets, jade, tourmaline, etc. . However, the disadvantage is that there are not many objective indicators or methods for verifying the efficacy.
혈중 콜레스테롤 농도가 일정한 수준보다 높아지는 고지혈증, 고중성지방혈증이 되면 혈액의 점성증가 및 죽상동맥경화 현상의 진행에 의해 혈액 흐름의 악화, 혈압 상승 및 말초혈관의 혈액 순환 장애를 초래하게 된다.   Hyperlipidemia and hypertriglyceridemia in which blood cholesterol levels rise above a certain level may lead to deterioration of blood flow, elevated blood pressure, and impaired blood circulation in blood vessels due to an increase in blood viscosity and atherosclerosis.
혈중 콜레스테롤 농도의 저감화 및 혈액 순환 개선에 관한 것으로서 주로 기능성 식품소재 관련 연구가 다양하게 이루어져 왔으며,  As for reducing blood cholesterol levels and improving blood circulation, various researches on functional food materials have been conducted.
소재별로는 식이섬유소, 전통 한약재 등의 식물성 추출물, 오메가3 계열의 EPA 및 DHA 함유 정제 어유, 필수 지방산 감마리노레인산에 대한 연구가 주로 진행되어 왔고, 해조류 유래 항고지혈증 활성 및 혈류 촉진 물질에 대한 관심도 점차 높아지고 있다. By material, research has been mainly conducted on plant extracts such as dietary fiber, traditional herbal medicines, refined fish oils containing omega-3 series EPA and DHA, and essential fatty acid gamma-linorenic acid, and interest in anti-hyperlipidemic activity and blood flow promoting substances derived from seaweeds. It is getting higher.
혈액 순환이 원활하게 되기 위해서는 혈액의 주요 성분인 적혈구 및 백혈구 세포가 서로 엉키지 않고 잘 분산되어 모세혈관까지 잘 통과할 수 있어야 한다. 콜로이드는 각 입자의 표면상에 약간의 음의 전기 전하를 띄게 되므로, 현탁액 상태로 존재한다.  In order for the blood circulation to be smooth, the main components of the blood, red blood cells and white blood cells should be well dispersed without intertwining each other and able to pass through the capillaries. Colloids are in suspension because they have a slight negative electrical charge on the surface of each particle.
혈액은 일종의 콜로이드 용액으로서 모든 혈액 세포는 약간의 음전하를 띄고 있다. 같은 전하의 입자는 서로 반발하게 되어 잘 분산된다.  Blood is a type of colloidal solution, and all blood cells have a slight negative charge. Particles of the same charge repel each other and disperse well.
이와 같은 입자의 표면 전하를 제타 포텐셜(zeta potential, 이하 ZP)이라 부르고 음의 경우 -mV 단위로 표시된다. 제타 포텐셜의 절대치가 매우 낮을 때 혈액의 응집이 시작되는데 이러한 현상을 혈관내 응고(intravascular coagulation)"라고 알려져 있다.  The surface charge of such particles is called the zeta potential (ZP) and negatively expressed in -mV units. The aggregation of blood begins when the absolute value of the zeta potential is very low, which is known as intravascular coagulation.
혈액이 슬러지 형태로 변하면 심장이 혈액을 뿜어내기가 어렵게 되고 통상적인 혈액의 기능이 약해져 심장질환을 일으키고 심하면 사망에 이르게 된다.  When the blood is turned into sludge, it is difficult for the heart to pump blood, and the normal function of blood is weakened, leading to heart disease, and even death.
따라서 혈액의 제타 포텐셜이 부(-)의 방향으로 절대치가 증가하게 되면 적혈구 세포는 보다 효율적이며 심장은 혈액을 쉽게 펌프할 수 있고, 혈액과 림프는 영양분을 잘 운반할 수 있으며, 체내 독성 잔여물을 보다 효율적으로 용해시키고 제거할 수 있다. Therefore, when the zeta potential of blood increases in the negative direction, red blood cells are more efficient, the heart can pump blood easily, the blood and lymph can carry nutrients well, and the toxic residues in the body Can be dissolved and removed more efficiently.
한편, 건강을 위하여 깨끗하고 좋은 물에 대한 관심이 증가하고 있다. Meanwhile, interest in clean and good water for health is increasing.
체중의 약 70%는 물로 구성되어 있으며 산소호흡과 더불어 물을 마시지 않고는 생명을 유지할 수 없다. 인체의 생명활동은 수 조개의 체세포(60조 개)와 수 조개의 장내 미생물 세포 즉 200조 개의 세포로 영위되는 생명 복합체이다.  About 70% of body weight is made up of water and can not sustain life without drinking water with oxygen breathing. The life activity of the human body is a life complex consisting of somatic cells (60 trillion) of clam and intestinal microbial cells of clam, or 200 trillion cells.
인체는 세포 내액과 세포 외액으로 구성되어 있는데 세포 내액은 체중의 30~40%, 세포 외액은 체중의 20~25%, 혈액은 83%가 각각 물이 차지하고 있다. 따라서 특정 세포 내로 물이 잘 흡수되어야 신진대사가 원활히 이루어질 수 있다. The human body is composed of intracellular and extracellular fluid. The intracellular fluid is 30-40% of the body weight, the extracellular fluid is 20-25% of the body weight, and the blood is 83%. Therefore, metabolism can be smoothly performed when water is well absorbed into specific cells.
따라서, 건강에 좋은 물을 제공하기 위하여 기능수(functional water)에 대한 특허가 다수 출원되고 있다.Therefore, many patents have been applied for functional water in order to provide healthy water.
종래 기능수에 대한 특허로는 대한민국 특허공개 제2006-114506에서는 (a) 공기를 활성공기 발생기에서 자화시켜 활성공기를 만든 후,  The patent for the conventional functional water is disclosed in the Republic of Korea Patent Publication No. 2006-114506 (a) after making the active air by magnetizing the air in the active air generator,
이를 수돗물 또는 지하수에 폭기하여 활성중산소를 포함하는 활성수를 제조하는 단계;  Aerated in tap water or ground water to prepare an active water containing active oxygen;
(b) 활성수를 반응기에 주입하고 미네랄 파우더를 투입한 후 감압 증류시켜 파우더로부터 미네랄을 용출 및 이온화시키는 단계;  (b) injecting active water into the reactor, adding mineral powder and distilling under reduced pressure to elute and ionize the mineral from the powder;
(c) 이온화된 미네랄을 함유하는 증기를 석관, 자석관 및 유리관으로 이루어진 응축기를 통하여 배출시키면서 응축시키는 단계; (d) 응축된 미네랄 함유 자화 활성수에 토코페롤, 유비퀴논, 철염을 혼합하는 단계를 포함하는 미네랄 함유 자화 활성 기능수의 제조방법 및 이에 따라 제조되는 미네랄 함유 자화 활성 기능수를 개시하고 있다. (c) condensing the vapor containing ionized minerals while discharging them through a condenser comprising a sarcophagus, a magnet tube and a glass tube; (d) Disclosed is a method for producing a mineral-containing magnetized active functional water comprising the step of mixing tocopherol, ubiquinone, and iron salt with the condensed mineral-containing magnetized active water and the mineral-containing magnetized active functional water produced accordingly.
대한민국 특허공개 제2006-108191호에서는 냉수통 혹은 저수통의 내부에 공급 되거나 보관되어지는 물을 일정한 수치의 기능성을 갖는 기능수를 항상 유지하여 보관할 수 있도록 순환 유로 형태로 이루어진 알칼리 환원수 생성장치를 개시하고 있다. Korean Patent Laid-Open Publication No. 2006-108191 discloses an alkaline reduced water generating device in the form of a circulating flow path so that water supplied or stored in a cold water container or a reservoir can always be maintained in a functional water having a certain level of functionality. Doing.
대한민국 특허공개 제2002-46369호에서는 수돗물 속에 함유된 유해 오염물질을 다수의 정수 필터를 이용하여 정제시키는 1단계 정제공정과; 1단계에서 정제된 물을 의료물질 생성장치를 통해 전기분해시키는 2단계 정제공정과;  Korean Patent Publication No. 2002-46369 discloses a one-step purification process for purifying hazardous contaminants contained in tap water using a plurality of water filters; A two-stage purification step of electrolyzing the water purified in the first step through a medical material generating device;
2단계에서 정제된 물을 생체기능조절유도체에 통과시켜 물성변화를 가하는 3단계 정제공정과;  A three-stage purification step of applying a change in physical properties by passing the water purified in the two-stage through a biological function control derivative;
상기 3단계에서 정제된 물을 세라믹 메달과 자철광의 금속산화물 광석을 통과시켜 물 분자를 콜로이드화 시키는 4단계 정제공정과;  A four-stage purification step of colliding water molecules by passing the water purified in the three-stage through a ceramic medallion and a metal oxide ore of magnetite;
4단계에서 정제된 물을 다수의 자외선 살균기를 통과시켜 살균처리하는 5단계 정제공정;을 수행함을 특징으로 하는 인체에 유용한 기능수의 제조방법을 개시하고 있다. It discloses a method of producing a functional water useful for the human body, characterized in that performing; five-step purification process for sterilizing the water purified in step 4 through a plurality of ultraviolet sterilizer.
대한민국 등록특허 제700923호에서는 고순도 천연규사나 인조규사 35~63.8 중량%, 식첨 무수탄산나트륨(Na2CO3) 31~59 중량%, 식첨 헥사메타인산나트륨 ((NaPO3)6) 3~15 중량%, 식첨 피로인산나트륨(Na4P2O7) 2~12 중량%, 식첨 탄산칼슘(CaCO3) 0.2~1 중량%로 상기 조성을 100 중량% 혼합하여 용해로에 넣어 용융한 후, 출탕하여 투명체의 결정을 얻은 후에 적당량의 증류수로 용해하여 pH 8~13의 규산염 성분이 함유된 음용수 첨가용 알칼리수를 얻는 제조제법을 개시하고 있다.In Korean Patent No. 700923, high purity natural silica or artificial silica 35 to 63.8 wt%, dietary anhydrous sodium carbonate (Na 2 CO 3 ) 31 to 59 wt%, dietary hexametaphosphate ((NaPO 3 ) 6 ) 3 to 15 weight %, 2-12% by weight of sodium pyrophosphate (Na 4 P 2 O 7 ), 0.2-1% by weight of calcium carbonate (CaCO 3 ), 100% by weight of the composition, mixed in a melting furnace and melted, The preparation method which obtains the alkali water for drinking water addition containing the silicate component of pH 8-13 by dissolving in a suitable quantity of distilled water after obtaining the crystal | crystallization of is disclosed.
그러나 상기 기능수들의 제조방법은 복잡하며, 아직까지 상기 기능수들의 혈액순환 개선에 대한 효능은 구체적으로 밝혀진 바가 없다.  However, the manufacturing method of the functional water is complicated, and the effect of improving the blood circulation of the functional water has not been specifically identified.
또한, 일본 특허공개 제2005-28341호에서는 전자파의 파형 분포 공역내에 실리카 미립자를 분산시킨 물을 통과시켜 물의 제타 전위의 절대치를 20 mV~60 mV로 올려 용해성, 침투성 등의 물의 기능을 지속적으로 유지하는 기능수를 제공하고 있다. 그러나, 상기 기능수는 불용성 실리카미립자를 사용함으로써 법규상 음용수로 사용할 수 없는 문제가 있다. In addition, Japanese Patent Application Laid-Open No. 2005-28341 passes water in which silica fine particles are dispersed in the waveform distribution space of electromagnetic waves, thereby raising the absolute value of the zeta potential of the water to 20 mV to 60 mV to continuously maintain water functions such as solubility and permeability. It provides a function number to do. However, there is a problem that the functional water cannot be used as drinking water by law by using insoluble silica fine particles.
이에 본 발명자들은 약품이나 건강 보조 식품과 같은 어떠한 유기물의 첨가없이 혈액순환을 개선할 수 있는 음용수를 개발하고자 연구한 결과, 음용수의 경도 및 pH의 조절, 규소 미네랄 첨가, 자화처리를 통해 표면장력을 낮춤으로서 음용시 즉시 혈관으로 물이 흡수되어 혈액과 상호 작용하고, 물의 제타 포텐셜을 증가시킴으로써 혈액의 점성을 낮출 수도 있고 혈액의 정상적인 제타 포텐셜을 유지하여 혈액순환을 원활히 할 수 있음을 알아내고 본 발명을 완성하였다. Therefore, the present inventors have studied to develop drinking water that can improve blood circulation without adding any organic substances such as drugs or dietary supplements. As a result, the surface tension is improved by controlling the hardness and pH of drinking water, adding silicon minerals, and magnetizing. By lowering water, the water is immediately absorbed into the blood vessels when drinking, and interacts with the blood, increasing the zeta potential of the water to lower the viscosity of the blood, and maintaining the normal zeta potential of the blood to find out that the blood circulation can be smoothed. Was completed.
본 발명의 목적은 높은 제타포텐셜과 낮은 표면장력을 갖는 혈액순환 개선용 기능성 음용수를 제공하는데 있다. An object of the present invention is to provide a functional drinking water for improving blood circulation having high zeta potential and low surface tension.
본 발명의 다른 목적은 상기 혈액순환 개선용 기능성 음용수의 제조방법을 제공하는데 있다. Another object of the present invention is to provide a method of producing functional drinking water for improving blood circulation.
본 발명의 또 다른 목적은 물에 규산나트륨을 첨가함으로써 물의 제타포텐셜을 높이는 방법을 제공하는데 있다. It is another object of the present invention to provide a method of increasing the zeta potential of water by adding sodium silicate to water.
본 발명의 다른 목적은 물에 규산나트륨을 첨가함으로써 물의 표면장력을 낮추는 방법을 제공하는데 있다. Another object of the present invention is to provide a method of lowering the surface tension of water by adding sodium silicate to water.
본 발명의 또 다른 목적은 상기 혈액순환 개선용 기능성 음용수를 배출하는 기능성 음용수기를 제공하는데 있다. Still another object of the present invention is to provide a functional drinking water discharging functional drinking water for improving blood circulation.
상기 목적을 달성하기 위하여, 본 발명은 음용수에 규산나트륨을 첨가한 후 자화처리하여 제조된 혈액순환 개선용 기능성 음용수를 제공한다. In order to achieve the above object, the present invention provides a functional drinking water for improving blood circulation prepared by magnetizing after adding sodium silicate to drinking water.
또한, 본 발명은 경도가 40~120 mg/l인 일반 음용수에 수용성 규산염을 농도가 22.4~45 mg/l가 되도록 용해시키는 단계(단계 1); 및 In addition, the present invention comprises the steps of dissolving a water-soluble silicate in a general drinking water of 40 ~ 120 mg / l hardness so that the concentration is 22.4 ~ 45 mg / l (step 1); And
상기 단계 1에서 제조된 규산염 용액을 자화활성수 제조장치에 통과시켜 자화처리하는 단계(단계 2)를 포함하는 상기 혈액순환 개선용 기능성 음용수의 제조방법을 제공한다. It provides a method for producing the functional drinking water for improving blood circulation comprising the step (step 2) of the silicate solution prepared in step 1 to pass through the magnetized active water production apparatus.
나아가, 본 발명은 물에 규산나트륨을 첨가함으로써 물의 제타포텐셜을 높이는 방법을 제공한다. Furthermore, the present invention provides a method of increasing the zeta potential of water by adding sodium silicate to water.
또한, 본 발명은 물에 규산나트륨을 첨가함으로써 물의 표면장력을 낮추는 방법을 제공한다. The present invention also provides a method of lowering the surface tension of water by adding sodium silicate to water.
나아가, 본 발명은 상기 혈액순환 개선용 기능성 음용수를 배출하는 기능성 음용수기를 제공한다. Furthermore, the present invention provides a functional drinking water dispenser for discharging the functional drinking water for improving blood circulation.
본 발명에 의하면, 약품이나 건강 보조 식품처럼 어떠한 유기물의 첨가없이 음용수의 경도 및 pH의 조절, 규산염 첨가, 자화처리를 통해 물의 표면장력을 낮춤으로써 물의 클러스터가 작아서 물이 세포 내로 용이하게 흡수되어 혈액과  According to the present invention, by lowering the surface tension of water through the control of hardness and pH of drinking water, addition of silicate, and magnetization without the addition of any organic matter, such as medicines or dietary supplements, the cluster of water is small so that water is easily absorbed into cells and thus blood. and
상호작용할 수 있으며, 제타포텐셜을 증가시켜 혈액의 정상적인 제타포텐셜을 유지하고 혈액 내의 적혈구와 백혈구의 분산을 증가시켜 혈액이 원활하게 순환되므로 건강한 삶을 유지할 수 있다.By increasing the zeta potential to maintain normal zeta potential of blood and increase the distribution of red blood cells and white blood cells in the blood, blood flows smoothly to maintain a healthy life.
도 1~4는 본 발명의 일실시예에 따른 기능성 음용수 또는 일반 음용수가 딸기의 신선도에 미치는 영향을 나타내는 사진이다. 1 to 4 are photographs showing the effect of functional drinking water or general drinking water on the freshness of strawberries according to an embodiment of the present invention.
도 5~7은 본 발명의 일실시예에 따른 기능성 음용수 또는 일반 음용수가 장미꽃의 신선도에 미치는 영향을 나타내는 사진이다. 5 to 7 are photographs showing the effect of functional drinking water or general drinking water on the freshness of a rose according to an embodiment of the present invention.
도 8은 본 발명에 따른 기능성 음용수 또는 생리식염수가 혈액의 응집현상에 미치는 영향을 나타내는 사진이다. 8 is a photograph showing the effect of the functional drinking water or physiological saline according to the present invention the aggregation of blood.
도 9는 본 발명의 일실시예에 따른 기능성 음용수기의 개 9 is a functional drinking water container according to an embodiment of the present invention.
이하, 본 발명을 상세히 설명한다. Hereinafter, the present invention will be described in detail.
본 발명은 혈액순환 개선용 기능성 음용수를 제공한다. The present invention provides a functional drinking water for improving blood circulation.
본 발명에 따른 기능성 음용수는 수용성 규산염을 함유하고 자화처리되어 pH가 7.5~9.0이고, 제타포텐셜이 -14 ~ -30 mV이고, 표면장력이 55~62 mN/m인 것이 바람직하다.The functional drinking water according to the present invention preferably contains water-soluble silicate and is magnetized to have a pH of 7.5 to 9.0, a zeta potential of -14 to -30 mV, and a surface tension of 55 to 62 mN / m.
또한, 본 발명은 경도가 40~120 mg/ℓ인 일반 음용수에 수용성 규산염을 농도가 22.4~45 mg/ℓ가 되도록 용해시키는 단계(단계 1); 및 In addition, the present invention comprises the steps of dissolving a water-soluble silicate in a general drinking water having a hardness of 40 ~ 120 mg / L so that the concentration is 22.4 ~ 45 mg / L (step 1); And
상기 단계 1에서 제조된 규산염 용액을 자화활성수 제조장치에 통과시켜 자화처리하는 단계(단계 2)를 포함하는 상기 혈액순환 개선용 기능성 음용수의 제조방법을 제공한다. It provides a method for producing the functional drinking water for improving blood circulation comprising the step (step 2) of the silicate solution prepared in step 1 to pass through the magnetized active water production apparatus.
나아가, 본 발명은 물에 규산염을 첨가함으로써 제타 포텐셜을 증가시키는 방법을 제공한다. Furthermore, the present invention provides a method of increasing the zeta potential by adding silicate to water.
또한, 본 발명은 물에 규산염을 첨가함으로써 표면 장력을 감소시키는 방법을 제공한다.  The present invention also provides a method of reducing surface tension by adding silicate to water.
혈액은 일정한 온도 및 pH에서는 일정한 운동을 하지만, 그 전해질의 농도는 고정되어 있지 않고 이 전해질은 직접적으로 제타 포텐셜에 영향을 미친다.  Blood performs a constant movement at a constant temperature and pH, but the concentration of the electrolyte is not fixed and the electrolyte directly affects the zeta potential.
양이온 또는 다중 전해질은 제타 포텐셜을 점차적으로 낮추는 반면,  Cationic or polyelectrolytes gradually lower the zeta potential,
음이온 전해질은 제타 포텐셜을 증가시킨다. 이온의 원자가(Valence)는 전기영동 이동도(electrophoretic mobility)에 지대한 영향을 미치고, 정도는 다르게 나타나지만 콜로이드의 제타 포텐셜 증폭과도 관련이 있다.  Anionic electrolytes increase the zeta potential. The valence of ions has a profound effect on electrophoretic mobility and appears to varying degrees, but is also associated with the zeta potential amplification of colloids.
"슈루즈 하디 법칙(Schulze-Hardy rule)"에 의하면 2원자가의 양이온은 전기 음성 콜로이드의 응집에 있어서 단일 원자가 양이온의 약 20~80배 효과적이다.  According to the Schulze-Hardy rule, bivalent cations are about 20-80 times more effective than single-valent cations in the aggregation of electronegative colloids.
3원자가의 양이온(Al3+)의 경우는 10~100배로 나타나 다원자가 양이온일수록 그 효과는 크다. In the case of trivalent cations (Al 3+ ), they are 10 to 100 times higher.
`이와는 달리 다가의 음이온은 응집을 방해하여 분산성을 높인다. 예를 들면 구연산칼륨(potassium citrate)과 탄산수소칼륨(potassium bicarbonate)이 혼합된 물(pH 8.0~8.4)을 하루 8잔 이상 마시면 혈관 내 응집을 줄일 수 있다고 한다. 이러한 관점에서 금속이온과 착화합물을 잘 형성하는 EDTA를 이용하여 제타포텐셜을 증가시키면서 체내의 독성 중금속을 제거하는 소위 "EDTA 킬레이션 요법"이 알려져 있다. `In contrast, polyvalent anions increase the dispersibility by preventing aggregation. For example, drinking eight or more cups of water (pH 8.0-8.4) mixed with potassium citrate and potassium bicarbonate may reduce coagulation in the blood vessels. From this point of view, so-called "EDTA chelation therapy" which removes toxic heavy metals in the body while increasing zeta potential using EDTA which forms a complex with metal ions is known.
제타 포텐셜 증가의 관점에서 볼때 우리가 음용하고 있는 음용수(수돗물, 샘물, 정수기물 등)에는 Ca2+, Mg2+, Na+, K+등 양이온과 SO4 2-, CO3 2-, Cl-, HCO3 - 등의 음이온이 혼재하고 있다. From the point of view of increasing zeta potential, the drinking water (tap water, spring water, water purifier, etc.) we drink includes cations such as Ca 2+ , Mg 2+ , Na + , K + , and SO 4 2- , CO 3 2- , Cl Anions such as - and HCO 3 - are mixed.
따라서 이들 다원자가의 양이온을 전기 또는 화학적인 방법으로 제거하지 않고 물리적인 방법인 자화처리법으로 제타 포텐셜이 증가하는 사실을 확인한 바가 있다(특허 제0722302호).  Therefore, it has been confirmed that the zeta potential is increased by the magnetization method, which is a physical method, without removing these polyvalent cations by an electrical or chemical method (Patent No. 0722302).
또한, 일반 음용수에 대하여 자화처리 전후의 제타 포텐셜을 측정한 실험에서, 자화처리를 하지 않은 일반 음용수(대조군)는 제타 포텐셜이 -3.75 ~ -8.87 mV로 나타난 반면, 자화 처리 후의 제타 포텐셜은 -11.22 ~ -16.40 mV로서 부의 방향으로 5.11 ~ 9.70 mV 정도 증가하는 것으로 나타났다(표 1 참조).  In addition, in experiments in which zeta potential was measured before and after magnetization for normal drinking water, the zeta potential of the non-magnetized drinking water (control) was -3.75 to -8.87 mV, whereas the zeta potential after magnetization was -11.22 ~ 16.40 mV, increasing from 5.11 to 9.70 mV in the negative direction (see Table 1).
제타 포텐셜이 자화처리 전에 비하여 처리 후에 증가하는 것은 물속에 녹아 있는 양이온성 미네랄이 자장을 통과할 때(미약 전류가 흐름) 나노 입자로 바뀌면서 그 표면에 음의 전하량이 증가되어 나타나는 현상으로 추정되며 또한 이 입자에 음의 이온들이 부착되어 시너지 효과가 생기는 것으로 추정된다.  The increase in zeta potential after treatment compared to before magnetization is presumed to be caused by the increase of negative charge on the surface of cationic minerals dissolved in water as they pass through the magnetic field (weak current flows) into nanoparticles. It is estimated that negative ions are attached to these particles, causing synergistic effects.
혈액의 제타 포텐셜이 -14 ~ -30 mV이면 혈액세포의 정상적인 분산이 일어나 혈액순환이 원만히 일어나는 것으로 알려져 있다.  If the zeta potential of the blood is -14 ~ -30 mV, the normal circulation of the blood cells occurs, blood circulation is known to occur smoothly.
상기 자화처리만으로 약 -8 ~ -15 mV까지 변화시킬 수 있으나, 물속의 양이온 및 음이온의 농도(또는 경도)가 취수지역 또는 물의 정수방법에 따라 그 변화의 폭이 다르게 나타나므로, 이러한 문제점을 해결하기 위하여 물에 무기염을 첨가하여 정상혈액의 제타 포텐셜과 유사한 -18 ~ -25 mV에 근접할 수 있도록 하였다. 이에 독성이 없고 음용수 수질 기준에 부합되어 적정량을 첨가하는 것이 가능한 무기염 중에서 규산염(sodium silicate)을 주목하게 되었다.  The magnetization treatment can be changed to about -8 to -15 mV, but the concentration (or hardness) of the cations and anions in the water varies depending on the water intake zone or water purification method. To this end, mineral salts were added to the water to approach -18 ~ -25 mV, similar to the zeta potential of normal blood. In this regard, silicate (sodium silicate) was noted among inorganic salts which are not toxic and can be added in an appropriate amount in accordance with drinking water quality standards.
물속의 용존 미네랄이 음용수에 있어서 필수적이며, 특히 해양심층수에는 오랜 세월동안 균형을 유지해온 60여 종의 미네랄이 녹아 있고 그 청정성의 이유로 최근에 음용수로 곽광을 받게 되자 미네랄의 중요성이 점차 부각되고 있다.  Dissolved minerals in water are essential for drinking water, and especially in deep sea water, about 60 kinds of minerals that have been balanced for many years are dissolved. .
그러나 지구상에 흔한 실리콘(Si)의 중요성은 강조된 바가 거의 없다.  But the importance of silicon (Si), which is common on Earth, is hardly emphasized.
실리콘은 정상적인 뼈의 성장에 필수적이고 뼈의 칼슘 흡착을 증가시키는 역할을 하는 것으로 알려져 있다.  Silicon is known to be essential for normal bone growth and to increase calcium absorption in bone.
특히 동맥 경화는 동맥 혈관벽에 실리콘의 함량이 줄어드는데도 원인이 있는 것으로 알려져있다. 따라서 제타 포텐셜을 증가시킴과 동시에 혈액속의 실리콘 함량을 높여 주는 것은 매우 중요하다. In particular, atherosclerosis is known to be responsible for the decrease in the content of silicon in the arterial vessel walls. Therefore, it is very important to increase the zeta potential and increase the silicon content in the blood.
상기 규산염은 물에 잘 용해되고 규산 음이온을 띄고 있기에 매우 적합하다. 또한 상기 규산염은 물에 용해되면 알카리성 수용액이 되어 산성 체질을 알카리성 체질로 바꾸는데도 유리하다.  The silicate is well suited because it is well soluble in water and has a silicate anion. In addition, the silicate is an alkaline aqueous solution when dissolved in water, it is also advantageous to convert the acidic constitution to alkaline constitution.
상기 수용성 규산염에는 Na4SiO4, Na6Si2O7, Na2SiO3 등을 사용할 수 있으나, 가장 바람직한 규산염으로써 Na2SiO3을 사용할 수 있다. Na 4 SiO 4 , Na 6 Si 2 O 7 , Na 2 SiO 3 and the like may be used as the water-soluble silicate, but Na 2 SiO 3 may be used as the most preferable silicate.
표 2에서 나타낸 바와 같이, 시중에 유통되고 있는 15% 규산염 용액 0.2 ㎖를 100 ㎖ 샘물시료에 첨가한 후 자화 처리한 결과 제타 포텐셜은 -21.78 mV로 나타나 정상혈액의 제타 포텐셜과 유사한 제타 포텐셜을 나타냄을 확인하였다. As shown in Table 2, 0.2 ml of commercially available 15% silicate solution was added to a 100 ml sample, followed by magnetization, resulting in a zeta potential of -21.78 mV, indicating a zeta potential similar to that of normal blood. It was confirmed.
그러나, 샘물의 미네랄 농도에 따라서 제타 포텐셜이 다르게 나타날 수 있기 때문에 그 경도가 40 ㎎/ℓ이하인 경우는 천연 미네랄이 다량 함유되어 있는 해양심층수 또는 연안심층수를 적정량 첨가하여 경도가 40~120 ㎎/ℓ이 되도록 조정한 다음 규산염을 가하고 자화처리하는 것이 바람직하다.  However, since the zeta potential may be different depending on the mineral concentration of the spring water, when the hardness is 40 mg / l or less, the hardness is 40 ~ 120 mg / l by adding an appropriate amount of deep seawater or coastal deep water containing a large amount of natural minerals. It is preferable to adjust so as to add silicate and magnetize.
음용수로서는 음용수 수질 기준에 적합한 샘물, 수돗물, 정수기 통과 물, 해양 또는 연안심층수, 온천수 등 다양한 종류의 물이 적용될 수 있다. As drinking water, various kinds of water, such as spring water, tap water, water purifier passing water, marine or coastal deep water, and hot spring water, which meet drinking water quality standards, may be applied.
본 발명에 따른 기능성 음용수에 있어서, 상기 자화활성수 제조장치는 당업계에서 사용되는 자화활성수 제조장치를 사용할 수 있으며, 이에 제한되지 않는다. 예를 들면 대한민국 특허등록 제0722302호에 개시된 자화활성수 제조장치를 사용할 수 있다. In the functional drinking water according to the present invention, the magnetized active water production apparatus may use a magnetized active water production apparatus used in the art, but is not limited thereto. For example, the apparatus for producing magnetized active water disclosed in Korean Patent Registration No. 0722302 may be used.
또한, 본 발명에 따른 기능성 음용수는 표면장력을 감소시킨다. In addition, the functional drinking water according to the present invention reduces the surface tension.
Na2SiO3 원액(15%) 10, 5, 1, 0.1 ml에 증류수를 가하여 총 100 ㎖가 되도록 조정한 다음 표면장력을 측정한 결과, 증류수의 표면장력(72.66 mN/m)에 비하여 Na2SiO3의 농도가 0.1%일 때 64.7 mN/m으로 표면장력이 감소하였고, Na 2 Na 2 compared to SiO 3 stock solution (15%) 10, 5, 1, as a result of adding the distilled water to 0.1 ml measured following the surface tension was adjusted to a total of 100 ㎖, surface tension (72.66 mN / m) of distilled water When the concentration of SiO 3 is 0.1%, the surface tension decreases to 64.7 mN / m.
5%일 때에는 59.2 mN/m으로 감소하다가 10%가 되면 다시 71.5 mN/m으로 증가하는 것으로 나타났다.  At 5%, it decreased to 59.2 mN / m and then increased to 71.5 mN / m at 10%.
또한 규산나트륨의 농도가 1%인 수용액을 자화처리하면 표면장력이 59.5 mN/m로서 자화처리 전(62.6 mN/m)보다 3.1 mN/m 정도 감소하는 것으로 나타났다. 따라서, 본 발명에 따라 Na2SiO3을 첨가하여 자화처리한 기능성 음용수는 일반 증류수보다 표면장력이 낮기 때문에 물의 집단을 소형화할 수 있으며, 세포 내로 흡수가 빨라 혈관까지 빠른시간 내로 도달할 수 있어 혈액순환 개선을 촉진시킬 수 있다.In addition, when the aqueous solution of sodium silicate concentration of 1% was magnetized, the surface tension was 59.5 mN / m, which was 3.1 mN / m lower than that before the magnetization (62.6 mN / m). Therefore, functional drinking water magnetized by adding Na 2 SiO 3 according to the present invention has a lower surface tension than ordinary distilled water, so that the population of water can be miniaturized. Can improve circulation.
국내 음용수의 적정 pH는 5.8~8.5로 지정되어 있으나, 외국에는 특별한 기준치는 없고 pH 5.8~10의 범위를 권고하고 있다.  Although the optimal pH of domestic drinking water is specified as 5.8 ~ 8.5, there is no specific standard in foreign countries and the range of pH 5.8 ~ 10 is recommended.
이에 적합한 규산염의 농도는 알카리성인 pH 7.5~9.0의 범위에 속하는 0.15~0.3%가 바람직하며, 이 때(0.15%)의 Na2SiO3의 농도는 22.4~45 ㎎/ℓ에 해당된다.Suitable silicate concentration is preferably 0.15 to 0.3% in the range of alkaline pH 7.5 ~ 9.0, and the concentration of Na 2 SiO 3 at this time (0.15%) corresponds to 22.4 ~ 45 mg / l.
따라서, 경도가 40~120 ㎎/ℓ인 일반 음용수에 규산염을 가해 그 농도가 22.4~45 ㎎/ℓ가 되도록 조정한 다음 자화처리하면 pH 7.5~9.0인 약알칼리성의 제타 포텐셜이 정상 혈액과 흡사한 -14 ~ -30 mV이고, 표면장력이 55~62 mN/m인 기능성 음용수를 제조할 수 있다. Therefore, when silicate is added to general drinking water having a hardness of 40-120 mg / l, the concentration is adjusted to 22.4-45 mg / l, and then magnetized, the weak alkaline zeta potential of pH 7.5-9.0 is similar to that of normal blood. Functional drinking water with -14 to -30 mV and surface tension of 55 to 62 mN / m can be prepared.
본 발명에 따른 기능성 음용수는 높은 제타포텐셜과 낮은 표면장력을 가짐으로써 혈관에 빠르게 흡수되고 혈액 내 적혈구 및 백혈구의 분산을 높임으로써 혈액순환을 원활하게 유지시킬 수 있다. Functional drinking water according to the present invention has a high zeta potential and low surface tension can be quickly absorbed into the blood vessels and can maintain a smooth blood circulation by increasing the dispersion of red blood cells and white blood cells in the blood.
본 발명에 따른 기능성 음용수가 혈액순환에 효능이 있음을 알아보기 위하여, 본 발명에 따른 기능성 음용수와 일반 음용수에 딸기 또는 장미꽃을 넣고 실온에서 3~4일 방치하면서 신선도를 관찰한 결과, 일반 음용수에 넣은 딸기 또는 장미꽃은 쉽게 부패하여 곰팡이가 나타나고, 시들었으나,  In order to find out that the functional drinking water according to the present invention is effective in the blood circulation, put the strawberry or rose in the functional drinking water and the general drinking water according to the present invention and observed freshness while leaving at room temperature for 3 to 4 days, general drinking water Strawberries or roses put on it easily decay and appear mildewed,
본 발명에 따른 기능성 음용수에 넣은 딸기 또는 장미꽃은 처음에 넣은 그대로의 모습으로 신선하게 유지되는 것으로 나타났다(도 1~7 참조). Strawberries or roses in functional drinking water according to the present invention was found to remain fresh in its original form (see FIGS. 1 to 7 ).
이로써 본 발명에 따른 음용수는 식물 조직속으로 잘 흡수되고 수액의 순환을 지속적으로 원만하게 잘 이루게 함을 알 수 있다.  As a result, the drinking water according to the present invention is well absorbed into the plant tissue and it can be seen that the circulation of sap smoothly and smoothly.
또한, 일반 음용수를 마신 후와 본 발명에 따른 기능성 음용수를 마신 후에 약지에 분포판 모세혈관의 혈액순환을 관찰한 결과, 본 발명에 따른 기능성 음용수를 마신 후 30초 이후부터 혈액순환이 빠르게 진행되는 것으로 나타났다.  In addition, after drinking general drinking water and after drinking the functional drinking water according to the present invention, the blood circulation of the capillaries of the distribution plate was observed in the ring finger, after 30 seconds after drinking the functional drinking water according to the present invention, the blood circulation proceeds rapidly. Appeared.
따라서, 본 발명에 따른 기능성 음용수는 혈액순환 개선에 유용하게 사용될 수 있다. Therefore, the functional drinking water according to the present invention can be usefully used to improve blood circulation.
본 발명에 따른 기능성 음용수는 가공 없이 직접 음용하거나, 각종 혼합음료, 인삼, 녹차, 생약, 추출물의 용매로서 사용될 수 있고, 막걸리, 소주, 맥주, 포도주 등 각종 주류; 생리식염수, 포도당 링거 등 의료용 수액 제제 등에 사용될 수 있다.  Functional drinking water according to the present invention can be used directly without processing, or can be used as a solvent of various mixed drinks, ginseng, green tea, herbal medicines, extracts, various liquors such as rice wine, shochu, beer, wine; It can be used for medical sap preparations such as saline solution and glucose ringer.
또한, 수경 재배 등의 농업, 식품 산업분야 등 물을 사용하는 모든 분야에 적용되어 수액의 원활한 순환으로 식물의 신선도가 더욱 오래 유지될 것이며, 음용시 혈액의 원활한 순환으로 환경오염이 날로 심해지는 현실에서 각종 질병을 예방하고 건강한 삶을 유지해 가는데 매우 유용할 것이다.  In addition, it is applied to all fields that use water, such as agriculture and food industry, such as hydroponic cultivation, so that the freshness of the plant will be maintained longer by the smooth circulation of sap, and the environmental pollution gets worse due to the smooth circulation of blood when drinking. Will be very useful in preventing diseases and maintaining a healthy life.
본 발명에 따른 기능성 음용수는 가정에서 직접 제조할 수 있으며, 수돗물과 정수기를 이용할 경우, 기존 정수기 계통에 규산염 저장통 및 유입량 조절밸브, 자활활성수 제조 장치를 출수구 전단에 추가 설치하면 가정에서 직접 기능수를 만들어 사용할 수 있다. Functional drinking water according to the present invention can be produced directly at home, and when using tap water and water purifier, the installation of silicate reservoir and inlet flow control valve, self-activated active water production equipment in the existing water purifier system in front of the outlet, the functional water directly at home Can be used to create.
또한, 본 발명은 상기 기능성 음용수를 배출하는 음용수기를 제공한다. In addition, the present invention provides a drinking water dispenser for discharging the functional drinking water.
본 발명에 따른 상기 기능성 음용수기의 일실시형태는 도 9에 나타낸 바와 같이,One embodiment of the functional drinking water according to the present invention, as shown in Figure 9 ,
원수를 공급하는 원수 공급부(100);수용성 규산염을 저장하는 저장용기(200); Raw water supply unit 100 for supplying raw water; Storage vessel 200 for storing the water-soluble silicate;
상기 저장용기와 연통되어 수용성 규산염을 일정한 양만큼 토출하는 규산염 유입량 조절밸브(300); A silicate inflow control valve 300 in communication with the storage container for discharging the water-soluble silicate by a predetermined amount;
상기 원수 공급부에서 공급된 원수와 상기 규산염 유입량 조절밸브를 통하여 토출된 규산염을 혼합하여 자화시키는 자화활성수 제조장치(400); 및 Magnetized active water production apparatus 400 for magnetizing by mixing the raw water supplied from the raw water supply and the silicate discharged through the silicate inflow control valve; And
상기 자화활성수 제조장치에서 제조된 기능성 음용수를 기능수 배관을 거쳐 배출코크를 통하여 배출하는 기능수 배출부(500)를 포함할 수 있다. It may include a functional water discharge unit 500 for discharging the functional drinking water produced by the magnetized active water production apparatus through the discharge cock via the functional water pipe.
본 발명에 따른 음용수기에 있어서, 상기 원수 공급부(100)는 정수기, 이온수기, 생수 탱크 또는 수도전과 연결될 수 있다. In the drinking water according to the present invention, the raw water supply unit 100 may be connected to a water purifier, ionizer, bottled water tank or tap water.
본 발명에 따른 음용수기에 있어서, 상기 저장용기(200)는 수용성 규산염을 저장하며, 규산염 유입량 조절밸브를 통하여 규산염이 토출된다.  In the drinking water according to the present invention, the storage container 200 stores the water-soluble silicate, the silicate is discharged through the silicate inflow control valve.
이때 수용성 규산염은 Na2SiO3인 것이 바람직하며, 농도는 22.4~45 ㎎/ℓ인 것이 바람직하다.At this time, the water-soluble silicate is preferably Na 2 SiO 3 , the concentration is preferably 22.4 ~ 45 mg / l.
본 발명에 따른 음용수기에 있어서,  In the drinking water according to the present invention,
상기 원수 공급부에서 공급된 원수와 상기 규산염 유입량 조절밸브를 통하여 토출된 규산염이 혼합된 후에는 자화활성수 제조장치(400)로 이동하며, 이때 상기 자화활성수 제조장치는 당업계에서 사용되는 자화활성수 제조장치를 사용할 수 있으며, 이에 제한되지 않는다. 예를 들면 대한민국 특허등록 제0722302호에 개시된 자화활성수 제조장치를 사용할 수 있다. After the raw water supplied from the raw water supply unit and the silicate discharged through the silicate inflow control valve are mixed, the magnetized active water producing apparatus 400 is moved, and the magnetizing active water producing apparatus is used in the art. A water manufacturing apparatus may be used, but is not limited thereto. For example, the apparatus for producing magnetized active water disclosed in Korean Patent Registration No. 0722302 may be used.
본 발명에 따른 음용수기에 있어서, 상기 자화활성수 제조장치에서 제조된 기능성 음용수는 기능수 배출부(500)로 배출되어 사용될 수 있다. In the drinking water according to the present invention, the functional drinking water produced in the magnetized active water production apparatus may be discharged to the functional water discharge unit 500 to be used.
이하, 본 발명의 이해를 돕기 위하여 실험 및 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범위가 이에 한정되는 것은 아니다  Or less, but present experiments and preferred examples in order to help the understanding of the present invention, the following examples are merely to illustrate the present invention is not limited to the scope of the present invention.
<실시예 1> 음용수의 자화 처리 전후의 제타 포텐셜(Zeta Potential) 측정Example 1 Zeta Potential Measurement Before and After Magnetization of Drinking Water
일반 음용수의 자화활성수 제조기를 통과시키기 전후의 제타 포텐셜을 제타 포텐셜 측정장치(Particle Size/Zeta Potential Analyzer, Brookhaven Instruments Cooperation사)를 이용하여 측정하고 그 결과를 표 1에 나타내었다. 측정치는 5 ~ 10회 연속으로 측정하여 평균치로 표시하였다. The zeta potential before and after passing the magnetized active water generator of general drinking water was measured using a zeta potential measuring device (Particle Size / Zeta Potential Analyzer, Brookhaven Instruments Cooperation) and the results are shown in Table 1. The measured value was measured continuously 5 to 10 times and displayed as an average value.
이때, 제타 포텐셜은 용액 중에 콜로이드 형태로 입자들이 존재할 때 측정이 되고 그 값이 부(-)의 방향으로 크면 클수록 입자들이 상호 전기적 반발에 의하여 잘 분산될 수 있음을 보여주는 지표이다. At this time, the zeta potential is measured when the particles are present in the colloidal form in the solution, and the larger the value in the negative direction, the better the particles can be dispersed by mutual electrical repulsion.
표 1
시료 평균 제타 포텐셜(mV) 표준오차 증가치(-mV)
증류수 -3.75 1.47
증류수(자화처리) -11.22 1.13 7.47
수돗물 A -7.64 0.91
수돗물 A(자화처리) -15.68 0.57 8.04
수돗물 B -4.67 0.63
수돗물 B(자화처리) -14.37 1.58 9.70
약수 A -8.87 1.92
약수 A(자화처리) -16.40 2.17 7.53
지하수 A -8.16 1.21
지하수 A(자화처리) -13.27 0.81 5.11
Table 1
sample Average Zeta Potential (mV) Standard error Increment (-mV)
Distilled water -3.75 1.47
Distilled Water (Magnetic Treatment) -11.22 1.13 7.47
Tap Water A -7.64 0.91
Tap water A (magnetization) -15.68 0.57 8.04
Tap Water B -4.67 0.63
Tap water B (magnetization) -14.37 1.58 9.70
Divisor A -8.87 1.92
Divisor A (Magnetization) -16.40 2.17 7.53
Groundwater A -8.16 1.21
Groundwater A (magnetization) -13.27 0.81 5.11
표 1에 나타낸 바와 같이, 자화처리를 하지 않은 일반 음용수(대조군)는 제타 포텐셜이 -3.75 ~ -8.87 mV로 나타난 반면, 자화 처리 후의 제타 포텐셜은 -11.22 ~ -16.40 mV로서 부의 방향으로 5.11 ~ 9.70 mV 정도 증가한 것을 알 수 있다. 따라서, 자화처리 후 분산력이 증가함을 알 수 있다. As shown in Table 1, the zeta potential of non-magnetized drinking water (control) ranged from -3.75 to -8.87 mV, whereas the zeta potential after magnetization was -11.22 to -16.40 mV, ranging from 5.11 to 9.70 in the negative direction. It can be seen that the mV increased. Therefore, it can be seen that the dispersion force increases after the magnetization treatment.
<실시예 2> 본 발명에 따른 기능성 음용수의 제타 포텐셜 측정Example 2 Zeta Potential Measurement of Functional Drinking Water According to the Present Invention
상기 표 1의 지하수 A 100 ml에 규산나트륨(15%) 0.2 ml를 넣고 희석한 다음 자화처리하여 본 발명에 따른 기능성 음용수를 제조하고, 상기 기능성 음용수의 제타 포텐셜을 상기 실시예 1의 방법으로 10회 연속 측정하였다. 0.2 ml of sodium silicate (15%) was added to 100 ml of ground water A in Table 1, and diluted with magnetization to prepare a functional drinking water according to the present invention, and the zeta potential of the functional drinking water was measured by 10 in the method of Example 1. Measured continuously.
측정 결과를 표 2에 나타내었다.The measurement results are shown in Table 2.
표 2
구분 이동도(mobility) 제타 포텐셜(mV)
1회 -1.58 -22.32
2회 -1.37 -19.31
3회 -1.56 -21.93
4회 -1.57 -22.14
5회 -1.55 -21.84
6회 -1.79 -25.27
7회 -1.56 -21.92
8회 -1.48 -20.80
9회 -1.41 -19.89
10회 -1.59 -22.41
평균 -1.55 -21.78
표준오차 0.04 -0.51
TABLE 2
division Mobility Zeta Potential (mV)
1 time -1.58 -22.32
Episode 2 -1.37 -19.31
3rd time -1.56 -21.93
4 times -1.57 -22.14
5 times -1.55 -21.84
6th -1.79 -25.27
7th -1.56 -21.92
8th -1.48 -20.80
9th -1.41 -19.89
10th -1.59 -22.41
Average -1.55 -21.78
Standard error 0.04 -0.51
표 2에 나타낸 바와 같이, 음용수에 규산나트륨을 첨가함으로써 첨가 전(-13.27 mV)에 비해 부의 방향으로 8.51 mV 정도로 증가하였으며,  As shown in Table 2, by adding sodium silicate to drinking water, it increased to about 8.51 mV in the negative direction compared to before (-13.27 mV),
자화처리 전(-8.16 mV)에 비해 부의 방향으로 13.62 mV 정도로 크게 증가하여 정상 혈액의 제타 포텐셜(-14 ~ -30 mV)의 범위에 포함됨을 알 수 있다. 따라서, 본 발명에 따른 기능성 음용수는 정상 혈액의 제타 포텐셜 범위에 포함되어 혈액 순환을 원활히 하는데 도움을 줄 수 있다. Compared with the magnetization treatment (-8.16 mV), it is increased to about 13.62 mV in the negative direction, it can be seen that it is included in the range of zeta potential (-14 ~ -30 mV) of normal blood. Therefore, the functional drinking water according to the present invention may be included in the zeta potential range of normal blood to help smooth blood circulation.
<실시예 3> 규산나트륨이 물의 표면장력에 미치는 영향Example 3 Effect of Sodium Silicate on Surface Tension of Water
본 발명에 사용되는 규산나트륨이 물의 표면장력에 어떤 영향을 미치는지 알아보기 위하여 다음과 같은 실험을 수행하였다. In order to determine how the sodium silicate used in the present invention affects the surface tension of water, the following experiment was performed.
규산나트륨 원액(15%) 10, 5, 1, 0.1 ㎖에 증류수를 가하여 총 100 ㎖가 되도록 조정한 다음 표면장력 측정기(Tensiometer/Du Nuoy)를 이용하여 표면장력을 측정하고, 그 결과를 표 3에 나타내었다. Distilled water was added to 10, 5, 1, and 0.1 ml of sodium silicate solution (15%) to adjust the total amount to 100 ml. Then, the surface tension was measured using a Tensometer (Densiometer / Du Nuoy). Shown in
표 3
농도 (v/v) 평균 표면장력 (mN/m)
0.1% 64.7±0.2
1% 62.6±0.8
5% 59.2±1.0
10% 71.5±0.3
1% (자화처리) 59.5±0.1
증류수(대조군) 72.66
TABLE 3
Concentration (v / v) Average surface tension (mN / m)
0.1% 64.7 ± 0.2
One% 62.6 ± 0.8
5% 59.2 ± 1.0
10% 71.5 ± 0.3
1% (Magnetization) 59.5 ± 0.1
Distilled Water (Control) 72.66
표 3에 나타낸 바와 같이, 대조군(증류수)의 표면장력(72.66 mN/m)에 비하여 규산나트륨의 농도가 0.1%일 때 64.7 mN/m으로 표면장력이 감소하였고,  As shown in Table 3, the surface tension was reduced to 64.7 mN / m when the concentration of sodium silicate was 0.1% compared to the surface tension (72.66 mN / m) of the control group (distilled water),
5%일 때에는 59.2 mN/m으로 감소하다가 10%가 되면 다시 71.5 mN/m으로 증가하는 것으로 나타났다.  At 5%, it decreased to 59.2 mN / m and then increased to 71.5 mN / m at 10%.
또한 규산나트륨의 농도가 1%인 수용액을 자화처리하면 표면장력이 59.5 mN/m로서 자화처리 전(62.6 mN/m)보다 3.1 mN/m 정도 감소하는 것으로 나타났다. In addition, when the aqueous solution of sodium silicate concentration of 1% was magnetized, the surface tension was 59.5 mN / m, which was 3.1 mN / m lower than that before the magnetization (62.6 mN / m).
따라서, 본 발명에 따라 규산나트륨을 첨가하여 자화처리한 기능성 음용수는 일반 증류수보다 표면장력이 낮기 때문에 물의 집단을 소형화할 수 있으며, 세포 내로 흡수가 빨라 혈관까지 빠른시간 내로 도달할 수 있어 혈액 순환 개선을 촉진시킬 수 있다. Therefore, functional drinking water magnetized by adding sodium silicate according to the present invention has a lower surface tension than ordinary distilled water, so that the population of water can be miniaturized. Can promote.
<실시예 4> 신선도 측정Example 4 Freshness Measurement
본 발명에 따른 기능성 음용수가 혈액순환에 미치는 영향을 알아보기 위하여 딸기, 장미꽃 등의 식물을 대상으로 신선도 실험을 수행하였다. Freshness experiments were performed on plants such as strawberries and roses in order to examine the effects of functional drinking water on the blood circulation.
시중에 판매되고 있는 음용수(국산 샘물, 수입 샘물, 해양심층수), 수돗물, 본 발명에 따른 기능성 음용수(규산염 0.2%, MGT-FW)에 딸기를 2등분하여  Divided strawberries into drinking water (domestic spring water, imported spring water, deep sea water), tap water, and functional drinking water (0.2% silicate, MGT-FW) according to the present invention.
각각의 음용수가 담긴 유리 그릇에 넣은 다음 3~4일 방치하면서 부패 또는 곰팡이가 성장하는 과정을 카메라로 촬영하여 비교하였다.  Each drinking water was placed in a glass bowl and left for 3 to 4 days to compare the growth of the fungus or fungus with a camera.
이후, 장미꽃을 대상으로 동일한 실험을 수행하였다. 그 결과를 도 1~7에 나타내었다.Then, the same experiment was performed on the rose. The results are shown in FIGS. 1 to 7 .
도 1의 (a)는 일반 국내 샘물에 넣은 딸기이고, (b)는 본 발명에 따른 기능성 음용수에 넣은 딸기이다. 1 (a) is a strawberry placed in a general domestic spring water, (b) is a strawberry placed in a functional drinking water according to the present invention.
도 2의 (a)는 수돗물에 넣은 딸기이고, (b)는 본 발명에 따른 기능성 음용수에 넣은 딸기이다. Figure 2 (a) is a strawberry in tap water, (b) is a strawberry in functional drinking water according to the present invention.
도 3의 (a)는 국내 약수에 넣은 딸기이고, (b)는 본 발명에 따른 기능성 음용수에 넣은 딸기이다. Figure 3 (a) is a strawberry in domestic drinking water, (b) is a strawberry in functional drinking water according to the present invention.
도 4의 (a)는 해양심층수에 넣은 딸기이고, (b)는 본 발명에 따른 기능성 음용수에 넣은 딸기이다. Figure 4 (a) is a strawberry in deep sea water, (b) is a strawberry in functional drinking water according to the present invention.
도 5의 (a)는 수소수에 꽂아 놓은 장미꽃이고, (b)는 본 발명에 따른 기능성 음용수에 꽂아 놓은 장미꽃이다. Figure 5 (a) is a rose plugged in hydrogen water, (b) is a rose plugged in functional drinking water according to the present invention.
도 6의 (a)는 해양심층수에 꽂아 놓은 장미꽃이고, (b)는 본 발명에 따른 기능성 음용수에 꽂아 놓은 장미꽃이다. Figure 6 (a) is a rose plugged into the deep sea water, (b) is a rose plugged into the functional drinking water according to the present invention.
도 7의 (a)는 국내 약수에 꽂아 놓은 장미꽃이고, (b)는 본 발명에 따른 기능성 음용수에 꽂아 놓은 장미꽃이다. Figure 7 (a) is a rose plugged into the domestic weak water, (b) is a rose plugged into the functional drinking water according to the present invention.
도 1~7에 나타낸 바와 같이, 딸기 실험 결과 3~4일이 경과하면 일반 음용수에 넣은 딸기는 외관이 물러지고, 부패하여 곰팡이가 나타났으나, As shown in Figures 1-7 , after 3-4 days as a result of strawberry experiment, the strawberry put in the general drinking water, the appearance is decayed, decayed, mold appeared,
본 발명에 따른 기능성 음용수에 넣은 딸기는 처음에 넣은 그대로의 모습을 유지하는 것을 알 수 있다.  Strawberry in the functional drinking water according to the present invention can be seen to maintain the state as it was initially put.
또한, 장미꽃 실험에서도 일반 음용수에 꽂아 놓은 장미꽃은 쉽게 시드는 반면, 본 발명에 따른 기능성 음용수에 꽂아 놓은 장미꽃은 신선하게 유지되는 것으로 나타났다.  In addition, in the rose experiments, the rose inserted into the general drinking water was easily withered, while the rose inserted into the functional drinking water according to the present invention was found to be kept fresh.
이는 수액이 조직속으로 잘 흡수되고, 수액의 순환이 지속적으로 원만하게 잘 이루어지기 때문이다. 이와 같은 결과는 동물 실험에서도 혈액의 순환이 원만하게 잘 이루어질 수 있음을 암시해준다. This is because the sap is well absorbed into the tissue, and the circulation of the sap is smoothly and continuously. These results suggest that blood circulation can be smoothly achieved in animal experiments.
<실시예 4> 말초 모세 혈관의 혈류 관찰Example 4 Blood Flow Observation of Peripheral Capillaries
본 발명에 따른 기능성 음용수가 혈액 순환 개선에 효과가 있는지 알아보기 위하여 다음과 같은 실험을 수행하였다. In order to find out whether the functional drinking water according to the present invention is effective in improving blood circulation, the following experiment was performed.
휴대용 말초모세혈관관찰현미경(휘루 주식회사, 일본)을 이용하여 일반 음용수를 마신 후와 본 발명에 따른 기능성 음용수를 마신 후에 약지에 분포판 모세혈관의 혈액순환을 관찰하였다.  Blood circulation of the distribution plate capillaries in the ring finger was observed after drinking normal drinking water using a portable peripheral capillary observation microscope (Firu Corporation, Japan) and after drinking the functional drinking water according to the present invention.
관찰 결과, 본 발명에 따른 기능성 음용수를 마신 후 30초 이후부터 혈액순환이 빠르게 진행되었으며, 이는 일반 음용수를 마실 때와 비교하여 뚜렷한 차이가 있음을 확인하였다. As a result, the blood circulation rapidly progressed after 30 seconds after drinking the functional drinking water according to the present invention, and it was confirmed that there is a distinct difference compared to drinking normal drinking water.
따라서, 본 발명에 따른 기능성 음용수는 혈액 순환 개선에 효과를 보임으로써 혈액순환 장애를 예방하여 건강한 삶을 영위할 수 있다. Therefore, the functional drinking water according to the present invention can lead to a healthy life by preventing blood circulation disorder by showing an effect on improving blood circulation.
<실시예 5> 혈액 분산도 관찰 Example 5 Observation of Blood Dispersion
건강에 이상이 없는 62세의 남자 혈액을 채취하여 생리식염수와 1 : 1로 희석한 다음 실온에서 5분간 방치후 현미경 사진을 촬영하였고, 같은 방법으로 본 발명에 따른 기능성 음용수에 대해서도 실험하였다. 실험 결과를 도 8에 나타내었다.A 62-year-old male blood was collected without dilution with physiological saline and then 1: 1 and left at room temperature for 5 minutes. Micrographs were taken. The same procedure was followed for functional drinking water according to the present invention. The experimental results are shown in FIG. 8 .
도 8에서, (a)는 생리식염수로 희석한 혈액을 현미경으로 관찰한 사진이고, (b)는 본 발명에 따른 기능성 음용수로 희석한 혈액을 현미경으로 관찰할 사진이다. In Figure 8 , (a) is a microscopic picture of the blood diluted with physiological saline, (b) is a microscopic picture of the blood diluted with functional drinking water according to the present invention.
도 8에 나타낸 바와 같이, 생리식염수로 희석한 혈액은 적혈구가 모여 군락을 이루는 현상을 나타내는 반면, 본 발명에 따른 기능성 음용수로 희석한 혈액은 비교적 잘 분산되고 응집되는 현상이 거의 관찰되지 않았다. 따라서, 본 발명에 따른 기능성 음용수는 혈액의 분산이 잘 이루어지므로 혈액순환 개선에 유용하게 사용될 수 있다.As shown in FIG . 8 , blood diluted with physiological saline shows a phenomenon in which red blood cells are collected and form a colony, whereas blood diluted with functional drinking water according to the present invention is relatively well dispersed and aggregated. Therefore, the functional drinking water according to the present invention can be usefully used for improving blood circulation since the blood is well dispersed.
<실시예 6> 규산염이 생리식염수의 제타포텐셜에 미치는 영향Example 6 Effect of Silicate on Zeta Potential of Physiological Saline
병원에서 사용중인 생리식염수 주사액 100 ㎖에 대조군으로서 아무 처리하지 않은 것과 시험군으로서 규산나트륨 용액(15%) 0.15~0.2 ㎖를 넣고 희석한 다음 자화처리한 시료의 제타포텐셜 상기 실시예 1의 방법으로 10회 연속 측정하였다. To 100 ml of physiological saline injection solution used in the hospital, untreated as a control and 0.15 to 0.2 ml of sodium silicate solution (15%) as a test group were diluted and zeta potential of the magnetized sample by the method of Example 1 Ten consecutive measurements were taken.
측정 결과를 표 4에 나타내었다.The measurement results are shown in Table 4.
표 4
구분 제타 포텐셜(mV)
생리식염수(0.9% NaCl) 생리식염수+0.15% 규산염, 자화처리
1회 -11.04 -26.60
2회 -20.69 -11.62
3회 4.59 -27.98
4회 -18.37 -45.61
5회 -35.40 -28.59
6회 -10.79 -25.04
7회 14.10 -25.90
8회 34.04 -25.45
9회 -47.27 -17.41
10회 -10.47 -35.11
평균 -10.12 -26.85
표준오차 10.10 3.12
Table 4
division Zeta Potential (mV)
Saline (0.9% NaCl) Physiological saline + 0.15% silicate, magnetized
1 time -11.04 -26.60
Episode 2 -20.69 -11.62
3rd time 4.59 -27.98
4 times -18.37 -45.61
5 times -35.40 -28.59
6th -10.79 -25.04
7th 14.10 -25.90
8th 34.04 -25.45
9th -47.27 -17.41
10th -10.47 -35.11
Average -10.12 -26.85
Standard error 10.10 3.12
표 4에 나타낸 바와 같이, 생리식염수의 평균 제타포텐셜은 -10.12 mV로 나타났지만 오차범위가 크게 나타나 용액이 불안정 상태에 있음을 알 수 있다.  As shown in Table 4, the average zeta potential of physiological saline was -10.12 mV, but the error range was large, indicating that the solution was in an unstable state.
반면에 규산염을 가한후 자화처리한 경우는 비교적 안정화가 되어있고, 평균 제타 포텐셜도 -26.85 mV로 높게 나타났다. On the other hand, the magnetization after silicate addition was relatively stable and the average zeta potential was -26.85 mV.
따라서, 본 발명에 따른 기능성 음용수는 링거액 주사제로서 활용될 수 있다 Therefore, the functional drinking water according to the present invention can be utilized as Ringer's solution injection.

Claims (8)

  1. 수용성 규산염을 함유하고 자화처리된, pH가 7.5~9.0이고, 제타포텐셜이 -14 ~ -30 mV이고, 표면장력이 55~62 mN/m인 혈액순환 개선용 기능성 음용수. Functional drinking water for improving blood circulation, containing water-soluble silicate and magnetized, pH 7.5-9.0, zeta potential -14--30 mV, surface tension 55-62 mN / m.
  2. 제1항에 있어서,  The method of claim 1,
    상기 수용성 규산염은 Na2SiO3인 것을 특징으로 하는 혈액순환 개선용 기능성 음용수.The water-soluble silicate is Na 2 SiO 3 Functional drinking water for improving blood circulation.
  3. 제1항에 있어서, 상기 수용성 규산염의 농도는 22.4~45 mg/ℓ인 것을 특징으로 하는 혈액순환 개선용 기능성 음용수.According to claim 1, wherein the concentration of the water-soluble silicate is functional drinking water for improving blood circulation, characterized in that 22.4 ~ 45 mg / ℓ.
  4. 제1항에 있어서,  The method of claim 1,
    상기 기능성 음용수는 높은 제타포텐셜과 낮은 표면장력을 가짐으로써 혈관에 빠르게 흡수되고 혈액 내 적혈구 및 백혈구의 분산을 높임으로써 혈액순환을 개선하는 것을 특징으로 하는 혈액순환 개선용 기능성 음용수. The functional drinking water has a high zeta potential and a low surface tension to be rapidly absorbed into the blood vessels and functional blood for improving blood circulation, characterized in that to improve blood circulation by increasing the dispersion of red blood cells and white blood cells.
  5. 제1항에 있어서,  The method of claim 1,
    상기 기능성 음용수는 별도의 가공 없이 그대로 음용하거나, 혼합음료의 용매; 인삼, 녹차 또는 생약 추출물의 용매; 주류의 용매로서 사용되는 것을 특징으로 하는 혈액순환 개선용 기능성 음용수. The functional drinking water may be used as it is without additional processing, or the solvent of the mixed beverage; Solvent of ginseng, green tea or herbal extracts; Functional drinking water for improving blood circulation, characterized by being used as a solvent in alcoholic beverages.
  6. 경도가 40~120 mg/ℓ인 일반 음용수에 수용성 규산염을 농도가 22.4~45 mg/ℓ가 되도록 용해시키는 단계(단계 1); 및 Dissolving the water-soluble silicate in a general drinking water having a hardness of 40-120 mg / l such that the concentration is 22.4-45 mg / l (step 1); And
    상기 단계 1에서 제조된 규산염 용액을 자화활성수 제조장치에 통과시켜 자화처리하는 단계(단계 2)를 포함하는 제1항의 혈액순환 개선용 기능성 음용수의 제조방법. A method of producing functional drinking water for improving blood circulation according to claim 1, comprising the step (step 2) of magnetizing the silicate solution prepared in step 1 through a magnetized active water production apparatus.
  7. 제6항에 있어서,  The method of claim 6,
    상기 수용성 규산염은 Na2SiO3인 것을 특징으로 하는 혈액순환 개선용 기능성 음용수의 제조방법.The water-soluble silicate is Na 2 SiO 3 The method for producing functional drinking water for improving blood circulation.
  8. 제1항의 기능성 음용수를 함유하는 링거 주사액. Ringer's injection solution containing the functional drinking water of claim 1.
PCT/KR2010/004590 2009-07-14 2010-07-14 Functional drinking water for improving blood circulation, and method for preparing same WO2011008028A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090063982A KR100943204B1 (en) 2009-07-14 2009-07-14 Functional drinking water for the blood circulation improvement and preparation method thereof
KR10-2009-0063982 2009-07-14

Publications (3)

Publication Number Publication Date
WO2011008028A2 WO2011008028A2 (en) 2011-01-20
WO2011008028A3 WO2011008028A3 (en) 2011-05-19
WO2011008028A9 true WO2011008028A9 (en) 2011-07-07

Family

ID=42083578

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/004590 WO2011008028A2 (en) 2009-07-14 2010-07-14 Functional drinking water for improving blood circulation, and method for preparing same

Country Status (2)

Country Link
KR (1) KR100943204B1 (en)
WO (1) WO2011008028A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102742706A (en) * 2012-07-26 2012-10-24 上海钛金福业生物科技有限公司 Metasilicic acid tea bag capable of preventing cardiovascular disease
EP2711379A1 (en) 2012-09-21 2014-03-26 Basell Poliolefine Italia S.r.l. Process for the gas-phase polymerization of olefins
KR101397992B1 (en) * 2013-09-06 2014-05-27 정현희 A system for displaying product condition information

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL151288B1 (en) * 1986-04-07 1990-08-31 Method of magnetohydrodynamic water conditioning
AU1614700A (en) * 1998-11-10 2000-05-29 Integrity Technologies, Llc Method of generating aqueous silica network particles and compositions includingthe silica network particles
MXPA01012297A (en) * 1999-06-02 2002-07-30 Nalco Chemical Co Stable silica sols of high surface area and improved activity.
JP2002192169A (en) * 2000-12-27 2002-07-10 Ako Kasei Co Ltd Beverage using seawater as raw material and raw material water thereof
KR200408018Y1 (en) * 2005-09-29 2006-02-07 조동현 home total purifier
KR100722302B1 (en) 2005-12-31 2007-05-29 한국원자력연구원 Apparatus for making magnetized water

Also Published As

Publication number Publication date
WO2011008028A3 (en) 2011-05-19
WO2011008028A2 (en) 2011-01-20
KR100943204B1 (en) 2010-02-19

Similar Documents

Publication Publication Date Title
CN102639129B (en) Antimicrobial compositions containing free fatty
Chidambara Murthy et al. Study on wound healing activity of Punica granatum peel
BR0214772A (en) systems and methods for treating patients with processed liposuction cells
CN104688648B (en) A kind of composition for oral cavity and preparation method thereof
WO2011008028A9 (en) Functional drinking water for improving blood circulation, and method for preparing same
CN104207957B (en) A kind of fibroin conditioning liquid with koro whitening function and preparation method thereof
CN107737070A (en) Sterilization, skin care hand cleaning liquid
CN103126917B (en) Bionic gynecologic care solution and its preparation method
KR20080014728A (en) Silver/water, silver gels and silver-based compositions and methods for making and using the same
Munusamy et al. Green Synthesis of Copper Oxide Nanoparticles Synthesized by Terminalia chebula Dried Fruit Extract: Characterization and Antibacterial Action
Yang et al. Oral delivery of marine shellfish supramolecule peptides for skin wound healing
TWI277393B (en) Acidic solution of sparingly-soluble group IIA complexes
KR101390347B1 (en) Detergent composition comprising Sicyos angulatus extract as effective component
EP2040692A2 (en) Medical use of n-phenylpropenoyl-amino acid derivatives and related compounds
Zheng et al. Photothermally responsive icariin and carbon nanofiber modified hydrogels for the treatment of periodontitis
KR100439124B1 (en) Manufacturing process of Rock Composition for Magma Q water having antivirus and sterilization
Ponnuraj et al. Influence of Limonia acidissima L. against the biofilm forming Aeromonas hydrophila isolated from fresh water fishes
CN110613646A (en) Facial cleansing bubble containing hemp extract and preparation method thereof
KR20100047602A (en) Product comprising functional silk peptide bf-7
CN105012201B (en) The oral care product with anti-helicobacter pylori of the alcohol extract containing Chinese hawthorn seed
Guadarrama-Reyes et al. Green synthesis of silver nanoparticles using Heterotheca inuloides and its antimicrobial activity in catgut suture threads
RU2090089C1 (en) Method for preparing extract of propolis and propolis extract
Temikotan et al. Biosciences and Plant Biology
KR20040105313A (en) Magma Q stone composition for sterilization
CN107625703A (en) Stern protection cream of lotus positive electricity antibacterial maintenance film and preparation method thereof can be formed

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10800039

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(2) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 10800039

Country of ref document: EP

Kind code of ref document: A2